Show Notes
In today’s episode of One Thirty Biohacks, we sit down with Nathalie Niddam to unpack one of the most talked-about topics in modern health right now: GLP-1 medications and the new era of medical weight loss.
We cut through the noise and dive into what GLP-1s can actually do and what they can’t. Nathalie breaks down the science in a clear, grounded way, and we explore how these medications work, who they may be appropriate for, and why sustainability matters more than speed.
We talk about: • The biggest myths and misunderstandings around GLP-1s • What to consider before starting, and what “good use” looks like • How to protect muscle mass, metabolism, and long-term health • Side effects, rebound weight gain, and how to reduce common pitfalls • Why lifestyle foundations still matter even with powerful tools
About Nathalie Niddam Nathalie is a certified nutritionist, epigenetics coach, and the host of the podcast Longevity with Nathalie Niddam, where she explores cutting-edge longevity science, biohacking, and practical strategies for better health and performance.
Please note: This episode is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for guidance tailored to your situation. Hosted on Acast. See acast.com/privacy for more information.
More from One Thirty Biohacks
Red light therapy is everywhere. From LED masks to full-body panels, the technology is becoming increasingly popular. But how much do we really know about how it works, and how can we tell which devices are worth investing in?
What if the problem with Ozempic isn’t the peptide, it’s the dose?
Why does a supplement work brilliantly for one person and do almost nothing for another?
What if the future of longevity isn’t just about living longer, but changing how we age?
Could stem cells change the way we approach healing and regeneration? In this episode, Dr. Torbjörn Ogéus explores the science of stem cells, their role in tissue repair and the emerging research into pluripotent cells in adult blood.